摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

6-(4-methoxyphenyl)-2-(4-(aminosulfonyl)phenyl)pyridazin-3(2H)-one | 1160787-30-3

中文名称
——
中文别名
——
英文名称
6-(4-methoxyphenyl)-2-(4-(aminosulfonyl)phenyl)pyridazin-3(2H)-one
英文别名
6-(4-Methoxyphenyl)-2-benzenesulfonamidepyridazine-3(2H)-one;4-[3-(4-methoxyphenyl)-6-oxopyridazin-1-yl]benzenesulfonamide
6-(4-methoxyphenyl)-2-(4-(aminosulfonyl)phenyl)pyridazin-3(2H)-one化学式
CAS
1160787-30-3
化学式
C17H15N3O4S
mdl
——
分子量
357.39
InChiKey
NNNPBKBKVVJHAT-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.5
  • 重原子数:
    25
  • 可旋转键数:
    4
  • 环数:
    3.0
  • sp3杂化的碳原子比例:
    0.06
  • 拓扑面积:
    110
  • 氢给体数:
    1
  • 氢受体数:
    6

上下游信息

  • 下游产品
    中文名称 英文名称 CAS号 化学式 分子量

反应信息

  • 作为反应物:
    描述:
    6-(4-methoxyphenyl)-2-(4-(aminosulfonyl)phenyl)pyridazin-3(2H)-one氯甲酸乙酯potassium carbonate 作用下, 以 丙酮 为溶剂, 反应 18.0h, 以27.7%的产率得到ethyl ({4-[6-(4-methoxyphenyl)-3-oxopyridazin-2-yl]phenyl}sulfonyl)carbamate
    参考文献:
    名称:
    Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives
    摘要:
    Fifteen novel pyridazinone substituted benzenesulfonylurea derivatives (3a-o) were synthesized from corresponding sulfonamides derivatives via novel carbamates (2a-e). These were characterized by elemental analysis and various spectroscopic methods viz. IR, H-1 NMR, C-13 NMR and MS. Blood sugar lowering effect of thirteen (3a-c, 3e, 3g-o) sulfonylurea derivatives at the dose of 20 mg/kg (p.o.) were assessed using glucose tolerance test in normal and NIDDM (n2-STZ) rat models. All compounds except 3c, 3e and 3o almost completely prevented the rise of blood glucose of NIDDM rats as compared with NIDDM control. While compounds 3c and 3o showed more than 50% prevention in the rise of blood glucose levels. in glucose-fed normal rats these compounds at the same dose except 3e significantly prevented the rise of blood glucose (more than 50%) when compared with control of glucose-fed normal rats. From the results, novel compounds (3a-c, 3g-n) exhibited considerably potent blood glucose lowering activity and may be used as lead compounds for developing new antidiabetic drugs. Some structure-activity relationship was observed while varying nature of 'Ar' and 'R'. (C) 2008 Published by Elsevier Masson SAS.
    DOI:
    10.1016/j.ejmech.2008.12.013
  • 作为产物:
    描述:
    苯甲醚 在 aluminum (III) chloride 作用下, 以 乙醇 为溶剂, 反应 48.0h, 生成 6-(4-methoxyphenyl)-2-(4-(aminosulfonyl)phenyl)pyridazin-3(2H)-one
    参考文献:
    名称:
    一些新型的6-芳基-2-(对氨基磺酰基苯基)-哒嗪-3(2H)-一的合成及抗癌活性的评价
    摘要:
    通过适当的芳酰基丙烯酸和4-肼基苯磺酰胺盐酸盐在乙醇中的缩合,合成了一系列带有苯磺酰胺部分(2a - h)的新型哒嗪酮衍生物。美国国家癌症研究所评估了五种衍生物(2a,2b,2d,2g和2h)对人癌细胞的抗癌活性。在2小时显示针对SR(白血病)和NCI-H522(非小细胞肺癌)显着的活性用GI 50值小于0.1μM。它还对白血病(CCRF-CEM,HL-60(TB),K-562,MOLT-4,RPMI-8226),非小细胞肺癌(NCI-H460),结肠(HCT-116, HCT-15,HT29,KMI2,SW-620),中枢神经系统(SF-295),黑素瘤(MALME-3M,M14,MDA-MB-435 SK-MEL-5),卵巢癌(OVCAR-3,NCI / ADR- RES)和GI 50小于1.0μM的乳腺癌(MCF7)癌细胞系。2h的急性毒性研究表明,无胸腺裸鼠对腹膜内(400 mg /
    DOI:
    10.1016/j.ejmech.2012.01.026
点击查看最新优质反应信息

文献信息

  • Synthesis and evaluation of anticancer activity of some novel 6-aryl-2-(p-sulfamylphenyl)-pyridazin-3(2H)-ones
    作者:I.G. Rathish、Kalim Javed、Shamim Ahmad、Sameena Bano、M.S. Alam、Mymoona Akhter、K.K. Pillai、Syed Ovais、Mohammed Samim
    DOI:10.1016/j.ejmech.2012.01.026
    日期:2012.3
    condensation of appropriate aroylacrylic acid and 4-hydrazinobenzenesulfonamide hydrochloride in ethanol. Five derivatives (2a, 2b, 2d, 2g and 2h) were evaluated for their anticancer activity toward human cancer cell lines by the National Cancer Institute. The 2h showed remarkable activity against SR (leukemia) and NCI-H522 (non-small cell lung) with a GI50 value of less than 0.1 μM. It also displayed
    通过适当的芳酰基丙烯酸和4-肼基苯磺酰胺盐酸盐在乙醇中的缩合,合成了一系列带有苯磺酰胺部分(2a - h)的新型哒嗪酮衍生物。美国国家癌症研究所评估了五种衍生物(2a,2b,2d,2g和2h)对人癌细胞的抗癌活性。在2小时显示针对SR(白血病)和NCI-H522(非小细胞肺癌)显着的活性用GI 50值小于0.1μM。它还对白血病(CCRF-CEM,HL-60(TB),K-562,MOLT-4,RPMI-8226),非小细胞肺癌(NCI-H460),结肠(HCT-116, HCT-15,HT29,KMI2,SW-620),中枢神经系统(SF-295),黑素瘤(MALME-3M,M14,MDA-MB-435 SK-MEL-5),卵巢癌(OVCAR-3,NCI / ADR- RES)和GI 50小于1.0μM的乳腺癌(MCF7)癌细胞系。2h的急性毒性研究表明,无胸腺裸鼠对腹膜内(400 mg /
  • Synthesis and blood glucose lowering effect of novel pyridazinone substituted benzenesulfonylurea derivatives
    作者:I.G. Rathish、Kalim Javed、Sameena Bano、Shamim Ahmad、M.S. Alam、K.K. Pillai
    DOI:10.1016/j.ejmech.2008.12.013
    日期:2009.6
    Fifteen novel pyridazinone substituted benzenesulfonylurea derivatives (3a-o) were synthesized from corresponding sulfonamides derivatives via novel carbamates (2a-e). These were characterized by elemental analysis and various spectroscopic methods viz. IR, H-1 NMR, C-13 NMR and MS. Blood sugar lowering effect of thirteen (3a-c, 3e, 3g-o) sulfonylurea derivatives at the dose of 20 mg/kg (p.o.) were assessed using glucose tolerance test in normal and NIDDM (n2-STZ) rat models. All compounds except 3c, 3e and 3o almost completely prevented the rise of blood glucose of NIDDM rats as compared with NIDDM control. While compounds 3c and 3o showed more than 50% prevention in the rise of blood glucose levels. in glucose-fed normal rats these compounds at the same dose except 3e significantly prevented the rise of blood glucose (more than 50%) when compared with control of glucose-fed normal rats. From the results, novel compounds (3a-c, 3g-n) exhibited considerably potent blood glucose lowering activity and may be used as lead compounds for developing new antidiabetic drugs. Some structure-activity relationship was observed while varying nature of 'Ar' and 'R'. (C) 2008 Published by Elsevier Masson SAS.
查看更多